Quali-quantitative analysis of eight Rosmarinus officinalis essential oils of different origin. First report.

Aim. It is well known that the pharmacological activity of essential oils depends on their major components, which may vary enormously. The aim of the present study was to determine the chemical composition of samples of essential oil of rosemary of different origins, in order to identify the main therapeutic constituents, according to European Pharmacopoeian (EP). Material and Methods. Analytical GC/MS was carried out on a total of eight samples of essential oil of rosemary: seven samples were commercial products from producers located in different geographical areas; the last sample was prepared in our labo- ratory from fresh flowering terminal sprigs of rosemary collected in Siena’s Province. results. The most representative constituents of the essential oils tested, were 1,8-cineole and camphor. Other components also occurred in significant quantities in some samples, for example and α- and β-pinene, limonene and caryophyllene, in- dicating clear phytochemical differences among samples. discussion. The high quantity of eucalyptol and camphor detected in the samples made them particularly suited for treating minor respiratory disorders. Eucalyptol is expectorant and liquefies bronchial secretions; camphor increases the interval bet- ween inspiration and expiration and increases the activity of the parasympathetic nervous system, facilitating respiration. On the other hand, the essential oils analyzed by us were not suitable for perfume production, because they contained little or no positive aromatic components

Optimization of extraction of drugs containing polyphenols using an innovative technique

The role of polyphenols in human health nowadays is well established and these natural products, found in many plant species, are the active ingredients of drugs, food supplements and cosmetics. Extraction procedure is pivotal to obtain high quality herbal products but paradoxically this factor is often underrated and obsolete techniques are used. In this work we compared the classic and most used method of maceration and an innovative and standardized technique of extraction, Estrattore Naviglio((R)), processing ten common medicinal plants containing polyphenols and for each analysing specific biological markers such as flavonoids, anthocyanosides and caffeic derivatives in addition to total polyphenols content. Estrattore Naviglio((R)) guaranteed a significant improvement of the chemical quality of extracts combining effectiveness with rapidity and reproducibility. In this work we further investigated the optimization of drug extractions by replicating operations varying parameters setting on Estrattore Naviglio((R)) instrument

In vitro Digestion of Phaseolus vulgaris L. Cooked Beans Induces Autophagy in Colon Cancer Cells

Phaseolus vulgaris L. (common bean) contains high levels of proteins, unsaturated fatty acids, minerals, fibers, and vitamins, and for this reason, it represents an essential component of the diet. More than 40,000 varieties of beans have been recognized and are staple foods in the traditional cuisine of many countries. In addition to its high nutritional value, P. vulgaris is also characterized by its nutraceutical properties and favors environmental sustainability. In this manuscript, we studied two different varieties of P. vulgaris, Cannellino and Piattellino. We investigated the effects of traditional processing (soaking and cooking) and in vitro gastrointestinal digestion of beans on their phytochemical composition and anticancer activity. Using HT29 and HCT116 colon cancer cell lines, we showed that the extract obtained after gastrointestinal digestion of cooked beans (the bioaccessible fraction, BF) induces cell death through the induction of the autophagic process. We demonstrated that the BF of Cannellino and Piattellino beans at the concentration of 100 μg/mL reduces cell vitality, measured by MMT assay, of both HT29 (88.41% ± 5.79 and 94.38% ± 0.47) and HCT116 (86.29% ± 4.3 and 91.23% ± 0.52) cell lines. Consistently, the treatment of HT29 cells with 100 μg/mL of Cannellino and Piattellino BFs reduced clonogenicity by 95% ± 2.14 and 96% ± 0.49, respectively. Moreover, the activity of extracts appeared to be selective for colon cancer cells. The data shown in this work further confirm P. vulgaris to be among foods with beneficial effects for human health. © 2023 by the authors

Herbal products in Italy: the thin line between phytotherapy, nutrition and parapharmaceuticals; a normative overview of the fastest growing market in Europe

The Italian herbal products market is the most prosperous in Europe. The proof is represented by the use of these products in several marketing categories, ranging from medicine to nutrition and cosmetics. Market and legislation in Italy are at the same time cause and consequence of this peculiar situation. In fact, the legislation on botanical food supplements in Italy is very permissive and at the same time the market shows an overall satisfaction of users and strong feedback in terms of consumption, which brings a widening use of medicinal plants, formerly the prerogative of pharmaceuticals, to other fields such as nutrition. This review summarizes the market and normative panorama of herbal products in Italy, highlighting the blurred boundaries of health indications, marketing authorizations and quality controls between herbal medicines and non pharmaceutical products, such as food supplements, cosmetics and other herbal-based “parapharmaceuticals”

Skin Wound Healing: from Mediterranean ethnobotany to evidence based phytotherapy

Phytotherapy plays an important role in wound healing. Medicinal plants have represented for thousands of years the only remedy for wound care, and still maintain an important therapeutic role thanks to peculiar and desirable features of plant phytocomplexes. The use of herbal preparations exploiting synergistic and multitasking activities is distinctive of phytotherapy as a branch of pharmacology and could be alternative, more often complementary, to the use of monomolecular synthetic drugs. The European Medicines Agency (EMA), as well as World Health Organization (WHO) and European Scientific Cooperative on Phytotherapy (ESCOP), confirm that one of the most frequent indication for which many medicinal plants are used in the European Community and in the rest of the world, is the treatment of skin disorders and minor wounds. The study of medicinal plants used in wound healing has its origins in the ethnobotanical knowledge and in folk medicine. Ethnobotany encompasses both wild and domestic species, and is rooted in observation, relationship, needs and traditional ways of knowing. Various ethnobotanical investigations that took place in Italy and in Greece confirmed the use of many species enlisted by EMA, ESCOP and WHO for use in wound healing. The interviewed subjects provided important practical details about the use of medicinal plants for the treatment of tissue lesions and they also described how every single plant, as well as every preparation, is destined to a specific type of wound. This work summarizes the medicinal plants used in Mediterranean countries, particularly Italy and Greece, for wound healing, reporting mechanisms of action, clinical efficacy and peculiar characteristics. These data provide the rationale for using different natural remedies on different types of wounds, showing that local health seeking strategies can help in resolving wound healing problems

In vitro Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2

Except for specific vaccines and monoclonal antibodies, effective prophylactic or post-exposure therapeutic treatments are currently limited for COVID-19. Propolis, a honeybee's product, has been suggested as a potential candidate for treatment of COVID-19 for its immunomodulatory properties and for its powerful activity against various types of viruses, including common coronaviruses. However, direct evidence regarding the antiviral activities of this product still remains poorly documented. VERO E6 and CALU3 cell lines were infected with SARS-CoV-2 and cultured in the presence of 12.5 or 25 mu g/ml of a standardized Hydroalcoholic Extract acronym (sHEP) of Eurasian poplar type propolis and analyzed for viral RNA transcription, for cell damage by optical and electron microscopy, and for virus infectivity by viral titration at 2, 24, 48, and 72 h post-infection. The three main components of sHEP, caffeic acid phenethyl ester, galangin, and pinocembrin, were tested for the antiviral power, either alone or in combination. On both cell lines, sHEP showed significant effects mainly on CALU3 up to 48 h, i.e., some protection from cytopathic effects and consistent reduction of infected cell number, fewer viral particles inside cellular vesicles, reduction of viral titration in supernatants, dramatic drop of N gene negative sense RNA synthesis, and lower concentration of E gene RNA in cell extracts. Interestingly, pre-treatment of cells with sHEP before virus inoculation induced these same effects described previously and was not able to block virus entry. When used in combination, the three main constituents of sHEP showed antiviral activity at the same levels of sHEP. sHEP has a remarkable ability to hinder the replication of SARS-CoV-2, to limit new cycles of infection, and to protect host cells against the cytopathic effect, albeit with rather variable results. However, sHEP do not block the virus entry into the cells. The antiviral activity observed with the three main components of sHEP used in combination highlights that the mechanism underlying the antiviral activity of sHEP is probably the result of a synergistic effect. These data add further emphasis on the possible therapeutic role of this special honeybee's product as an adjuvant to official treatments of COVID-19 patients for its direct antiviral activity

Phytotherapy in the management of diabetes: a review

Phytotherapy has long been a source of medicinal products and over the years there have been many attempts to use herbal medicines for the treatment of diabetes. Several medicinal plants and their preparations have been demonstrated to act at key points of glucidic metabolism. The most common mechanisms of action found include the inhibition of -glucosidase and of AGE formation, the increase of GLUT-4 and PPARs expression and antioxidant activity. Despite the large amount of literature available, the actual clinical effectiveness of medicinal plants in controlling diabetes-related symptoms remains controversial and there is a crucial need for stronger evidence-based data. In this review, an overview of the medicinal plants, which use in the management of diabetes is supported by authoritative monographs, is provided. References to some species which are currently under increasing clinical investigation are also reported

Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2

Inflammatory bowel diseases, which consist of chronic inflammatory conditions of the colon and the small intestine, are considered a global disease of our modern society. Recently, the interest toward the use of herbal therapies for the management of inflammatory bowel diseases has increased because of their effectiveness and favourable safety profile, compared to conventional drugs. Boswellia serrata Roxb. and Curcuma longa L. are amongst the most promising herbal drugs, however, their clinical use in inflammatory bowel diseases is limited and little is known on their mechanism of action. The aim of this work was to investigate the effects of two phytochemically characterized extracts of B. serrata and C. longa in an in vitro model of intestinal inflammation. Their impact on cytokine release and reactive oxygen species production, as well as the maintenance of the intestinal barrier function and on intestinal mucosa immune cells infiltration, has been evaluated. The extracts showed a good protective effect on the intestinal epithelium at 1 µg/mL, with TEER values increasing by approximately 1.5 fold, compared to LPS-stimulated cells. C. longa showed an anti-inflammatory mechanism of action, reducing IL-8, TNF-α and IL-6 production by approximately 30%, 25% and 40%, respectively, compared to the inflammatory stimuli. B. serrata action was linked to its antioxidant effect, with ROS production being reduced by 25%, compared to H₂O₂-stimulated Caco-2 cells. C. longa and B. serrata resulted to be promising agents for the management of inflammatory bowel diseases by modulating in vitro parameters which have been identified in the clinical conditions